The influence of the environment on the development of thyroid tumors: A new appraisal

Endocrine-Related Cancer

Volumn 21, Issue 5, 2014, Pages T235-T254

  Marcello, M A ^a   Malandrino, P ^b   Almeida, J F M ^a   Martins, M B ^a   Cunha, L L ^a   Bufalo, N E ^a   Pellegriti, G ^b   Ward, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Oncology; Pathogenesis; Thyroid

Indexed keywords

XENOBIOTIC AGENT;

ADVERSE EFFECTS; ANIMAL; DIET; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; HUMAN; IONIZING RADIATION; RISK FACTOR; SMOKING; THYROID NEOPLASMS; VIRUS DISEASES; VOLCANO;

ANIMALS; DIET; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; HUMANS; RADIATION, IONIZING; RISK FACTORS; SMOKING; THYROID NEOPLASMS; VIRUS DISEASES; VOLCANIC ERUPTIONS; XENOBIOTICS;

EID: 84907569055     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0131     Document Type: Review

References (202)

1. 1993 Chernobyl 7 years after the disaster. Increased number of thyroid cancer. Lakartidningen 90 1934.
2. 2012 Vandetanib: too dangerous in medullary thyroid cancer. Prescrire International 21 233.
3. AIRTUM-Workgroup 2013 Cancer in children and adolescents. Epidemiologia e Prevenzione 37 (supplement 1) 1-296)
4. Allen NE, Appleby PN, Key TJ, Bueno-de-Mesquita HB, Ros MM, Kiemeney LA, Tjonneland A, Roswall N, Overvad K, Weikert S et al. 2012 Macronutrient intake and risk of urothelial cell carcinoma in the European Investigation into Cancer and Nutrition (EPIC). International Journal of Cancer 132 635-644. (doi:10.1002/ijc.27643)
5. Almeida JM, Marcello M, Bufalo N, Amaral LP, Rossi CL, Araujo PP, Tincani AJ & Ward LS 2013 EBV may play a role in the development of thyroid nodules. In 83rd Annual Meeting of the American Thyroid Association, pp A-88. San Juan, Porto Rico: Thyroid.
6. Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM & Au WW 1996 Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17 1923-1929. (doi:10.1093/carcin/17.9.1923)
7. Arnbjornsson E, Arnbjornsson A & Olafsson A 1986 Thyroid cancer incidence in relation to volcanic activity. Archives of Environmental Health 41 36-40. (doi:10.1080/00039896.1986.9935763)
8. Aschebrook-Kilfoy B, Neta G, Brenner AV, Hutchinson A, Pfeiffer RM, Sturgis EM, Xu L, Wheeler W, Doody MM, Chanock SJ et al. 2012 Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer. Endocrine-Related Cancer 19 333-344. (doi:10.1530/ERC-11-0372)
9. Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E & Devesa SS 2013a Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid 23 1015-1021. (doi:10.1089/thy.2012.0356)
10. Aschebrook-Kilfoy B, Kaplan EL, Chiu BC, Angelos P & Grogan RH 2013b The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Annals of Surgical Oncology 20 2746-2753. (doi:10.1245/s10434-013-2892-y)
11. Aschebrook-Kilfoy B, Shu XO, Gao YT, Ji BT, Yang G, Li HL, Rothman N, Chow WH, Zheng W & Ward MH 2013c Thyroid cancer risk and dietary nitrate and nitrite intake in the Shanghai Women's Health Study. International Journal of Cancer 132 897-904. (doi:10.1002/ijc.27659)
12. Avanzi S, Alvisi G & Ripalti A 2013 How virus persistence can initiate the tumorigenesis process. World Journal of Virology 2 102-109. (doi:10.5501/wjv.v2.i2.102)
13. Bandurska-Stankiewicz E, Aksamit-Bialoszewska E, Rutkowska J, Stankiewicz A & Shafie D 2011 The effect of nutritional habits and addictions on the incidence of thyroid carcinoma in the Olsztyn province of Poland. Endokrynologia Polska 62 145-150.
14. Barbieri RB, Bufalo NE, Secolin R, Silva AC, Assumpcao LV, Maciel RM, Cerutti JM & Ward LS 2012 Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. European Journal of Endocrinology 166 241-245. (doi:10.1530/EJE-11-0843)
15. Barbieri RB, Bufalo NE, Cunha LL, Assumpcao LV, Maciel RM, Cerutti JM & Ward LS 2013 Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk. Clinical Endocrinology 79 288-293. (doi:10.1111/cen.12136)
16. Bartholomeusz C & Gonzalez-Angulo AM 2012 Targeting the PI3K signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets 16 121-130. (doi:10.1517/14728222.2011.644788)
17. Bartsch H & Hietanen E 1996 The role of individual susceptibility in cancer burden related to environmental exposure. Environmental Health Perspectives 104 (Suppl 3) 569-577. (doi:10.1289/ehp.96104s3569)
18. Bartsch H, Nair U, Risch A, Rojas M, Wikman H & Alexandrov K 2000 Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiology, Biomarkers & Prevention 9 3-28.
19. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C & Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. American Journal of Medicine 93 363-369. (doi:10.1016/0002-9343(92)90164-7)
20. Biondi B, Arpaia D, Montuori P, Ciancia G, Ippolito S, Pettinato G & Triassi M 2012 Under the shadow of Vesuvius: a risk for thyroid cancer? Thyroid 22 1296-1297. (doi:10.1089/thy.2012.0002)
21. Bois FY, Krowech G & Zeise L 1995 Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl. Risk Analysis 15 205-213. (doi:10.1111/j.1539-6924.1995.tb00314.x)
22. Bosetti C, Kolonel L, Negri E, Ron E, Franceschi S, Dal Maso L, Galanti MR, Mark SD, Preston-Martin S, McTiernan A et al. 2001 A pooled analysis of case-control studies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes & Control 12 375-382. (doi:10.1023/A:1011267123398)
23. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M & Suarez HG 1997 High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15 1263-1273. (doi:10.1038/sj.onc.1200206)
24. Brusca L, Aiuppa A, D'Alessandro W, Parello F, Allard P & Michel A 2001 Geochemical mapping of magmatic gas-water-rock interactions in the acquifer of Mount Etna volcano. Journal of Volcanology and Geothermal Research 108 199-218. (doi:10.1016/S0377-0273(00)00286-9)
25. Bufalo NE, Leite JL, Guilhen AC, Morari EC, Granja F, Assumpcao LV & Ward LS 2006 Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocrine-Related Cancer 13 1185-1193. (doi:10.1677/ERC-06-0002)
26. Burridge E 2003 Bisphenol A: product profile. European Chemical News 17 14-20.
27. Capen CC 1997 Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicologic Pathology 25 39-48. (doi:10.1177/019262339702500109)
28. 131I in childhood. Journal of the National Cancer Institute 97 724-732. (doi:10.1093/jnci/dji129)
29. Caudill CM, Zhu Z, Ciampi R, Stringer JR & Nikiforov YE 2005 Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to g-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. Journal of Clinical Endocrinology and Metabolism 90 2364-2369. (doi:10.1210/jc.2004-1811)
30. CDC 2010 Smoking and tobacco use. Chemical in Tobacco Smoke. Atlanta: CDC. http://www.cdc.gov/tobacco/data-statistics/sgr/2010/consumer-booklet/chemicals-smoke/
31. Chen AY, Jemal A & Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115 3801-3807. (doi:10.1002/cncr.24416)
32. Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA & Nikiforov YE 2005 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. Journal of Clinical Investigation 115 94-101. (doi:10.1172/JCI23237)
33. Cleaver AL, Bhamidipaty K, Wylie B, Connor T, Robinson C, Robinson BW, Mutsaers SE & Lake RA 2014 Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance. Carcinogenesis 35 407-414. (doi:10.1093/carcin/bgt322)
34. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW & Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute 95 625-627. (doi:10.1093/jnci/95.8.625)
35. Coles B & Ketterer B 1990 The role of glutathione and glutathione transferases in chemical carcinogenesis. Critical Reviews in Biochemistry and Molecular Biology 25 47-70. (doi:10.3109/10409239009090605)
36. Collins BJ, Chiappetta G, Schneider AB, SantoroM, Pentimalli F, Fogelfeld L, Gierlowski T, Shore-Freedman E, Jaffe G & Fusco A 2002 RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. Journal of Clinical Endocrinology and Metabolism 87 3941-3946. (doi:10.1210/jcem.87.8.8748)
37. Comba P, Gianfagna A & Paoletti L 2003 Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Archives of Environmental Health 58 229-232. (doi:10.3200/AEOH.58.4.229-232)
38. Cronkite EP, Bond VP & Conard RA 1995 Medical effects of exposure of human beings to fallout radiation from a thermonuclear explosion. Stem Cells 13 (Suppl 1) 49-57.
39. Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, Gronbaek H, Tjonneland A, Halkjaer J, Dossus L et al. 2009 The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology, Biomarkers & Prevention 18 1333-1340. (doi:10.1158/1055-9965.EPI-08-0781)
40. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M & Boyle P 2007 Cancer incidence in five continents, vol. IX. In IARC Scientific Publications No. 160. Lyon, France: IARC.
41. Dahal BM, Fuerhacker M, Mentler A, Karki KB, Shrestha RR & Blum WE 2008 Arsenic contamination of soils and agricultural plants through irrigation water in Nepal. Environmental Pollution 155 157-163. (doi:10.1016/j.envpol.2007.10.024)
42. D'Alessandro 2005 Human fluorosis related to volcanic activity a review. In Environmental Toxicology, pp 21-30. Eds AG Kungolos, CA Brebbia, CP Samaras, & V Popov. Southampton, UK: WIT Press.
43. D'Alessandro W & Vita F 2003 Groundwater radon measurements in the Mt. Etna area. Journal of Environmental Radioactivity 65 187-201. (doi:10.1016/S0265-931X(02)00096-6)
44. David H, Mendoza S, Konishi T & Miller CW 2001 Simian virus 40 is present in human lymphomas and normal blood. Cancer Letters 162 57-64. (doi:10.1016/S0304-3835(00)00628-5)
45. Davies L & Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 295 2164-2167. (doi:10.1001/jama.295.18.2164)
46. De Groef B, Decallonne BR, Van der Geyten S, Darras VM & Bouillon R 2006 Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects. European Journal of Endocrinology 155 17-25. (doi:10.1530/eje.1.02190)
47. Dijkstra B, Prichard RS, Lee A, Kelly LM, Smyth PP, Crotty T, McDermott EW, Hill AD & O'Higgins N 2007 Changing patterns of thyroid carcinoma. Irish Journal of Medical Science 176 87-90. (doi:10.1007/s11845-007-0041-y)
48. Divi RL, Chang HC & Doerge DR 1997 Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochemical Pharmacology 54 1087-1096. (doi:10.1016/S0006-2952(97)00301-8)
49. +/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. PNAS 104 20250-20255. (doi:10.1073/pnas.0707207104)
50. Duffy BJ Jr & Fitzgerald PJ 1950 Cancer of the thyroid in children: a report of 28 cases. Journal of Clinical Endocrinology and Metabolism 10 1296-1308. (doi:10.1210/jcem-10-10-1296)
51. Duntas LH & Doumas C 2009 The 'rings of fire' and thyroid cancer. Hormones 8 249-253. (doi:10.14310/horm.2002.1242)
52. Elisei R 2014 Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it? Journal of Clinical Endocrinology and Metabolism 99 412-414. (doi:10.1210/jc.2014-1130)
53. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G et al. 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question Journal of Clinical Endocrinology and Metabolism 95 1516-1527. (doi:10.1210/jc.2009-1536)
54. Emi Y, Ikushiro S & Kato Y 2007 Thyroxine-metabolizing rat uridine diphosphate-glucuronosyltransferase 1A7 is regulated by thyroid hormone receptor. Endocrinology 148 6124-6133. (doi:10.1210/en.2007-0443)
55. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE & Devesa SS 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology, Biomarkers & Prevention 18 784-791. (doi:10.1158/1055-9965.EPI-08-0960)
56. Ericsson UB & Lindgarde F 1991 Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. Journal of Internal Medicine 229 67-71. (doi:10.1111/j.1365-2796.1991.tb00308.x)
57. Favalli M, Mazzarini F, Pareschi MT & Boschi E 2004 Role of local wind circulation in plume monitoring at Mt. Etna volcano (Sicily): insights from a mesoscale numerical model. Geophysical Research Letters 31 L09105. (doi:10.1029/2003GL01928)
58. Fincham SM, Ugnat AM, Hill GB, Kreiger N & Mao Y 2000 Is occupation a risk factor for thyroid cancer? Canadian Cancer Registries Epidemiology Research Group Journal of Occupational and Environmental Medicine 42 318-322. (doi:10.1097/00043764-200003000-00013)
59. Fiore AP, Fuziwara CS & Kimura ET 2009 High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells. Thyroid 19 1249-1256. (doi:10.1089/thy.2008.0408)
60. V600E mutation and the biology of papillary thyroid cancer. Endocrine-Related Cancer 15 191-205. (doi:10.1677/ERC-07-0212)
61. Fuentes-Gonzalez AM, Contreras-Paredes A, Manzo-Merino J & Lizano M 2013 The modulation of apoptosis by oncogenic viruses. Virology Journal 10 182. (doi:10.1186/1743-422X-10-182)
62. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP et al. 1995 Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Research 55 5617-5620.
63. Fuziwara CS & Kimura ET 2013 High iodine blocks a Notch/miR-19 loop activated by the BRAFV600E oncoprotein and restores the response to TGFb in thyroid follicular cells. Thyroid 24 453-462. (doi:10.1089/thy.2013.0398)
64. Galanti MR, Hansson L, Lund E, Bergstrom R, Grimelius L, Stalsberg H, Carlsen E, Baron JA, Persson I & Ekbom A 1996 Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiology, Biomarkers & Prevention 5 425-431.
65. Gaspar J, Rodrigues S, Gil OM, Manita I, Ferreira TC, Limbert E, Goncalves L, Pina JE & Rueff J 2004 Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genetics and Cytogenetics 151 60-67. (doi:10.1016/j.cancergencyto.2003.09.018)
66. Gentilcore D, Porreca I, Rizzo F, Ganbaatar E, Carchia E, Mallardo M, De Felice M & Ambrosino C 2013 Bisphenol A interferes with thyroid specific gene expression. Toxicology 304 21-31. (doi:10.1016/j.tox.2012.12.001)
67. Giammanco S, Valenza M, Pignato S & Giammanco G 1996 Mg, Mn, Fe, and V concentrations in the ground waters of Mount Etna (Sicily). Water Research 30 378-386. (doi:10.1016/0043-1354(95)00183-2)
68. Gomez Saez JM 2011 Diagnostic and prognostic markers in differentiated thyroid cancer. Current Genomics 12 597-608. (doi:10.2174/138920211798120826)
69. Goodman MT, Yoshizawa CN & Kolonel LN 1988 Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 61 1272-1281. (doi:10.1002/1097-0142(19880315)61:6〈1272::AID-CNCR2820610636〉3.0.CO;2-8)
70. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV & Ward LS 2004a GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Letters 209 129-137. (doi:10.1016/j.canlet.2003.12.013)
71. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV & Ward LS 2004b Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 210 151-157. (doi:10.1016/j.canlet.2004.01.016)
72. Granja F, Morari EC, Assumpcao LV & Ward LS 2005 GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy. European Journal of Cancer Prevention 14 277-280. (doi:10.1097/00008469-200506000-00013)
73. Grimalt JO, Sunyer J, Moreno V, Amaral OC, Sala M, Rosell A, Anto JM & Albaiges J 1994 Risk excess of soft-tissue sarcoma and thyroid cancer in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content. International Journal of Cancer 56 200-203. (doi:10.1002/ijc.2910560209)
74. Grywalska E, Markowicz J, Grabarczyk P, Pasiarski M & Rolinski J 2013 Epstein-Barr virus-associated lymphoproliferative disorders. Postepy Higieny i Medycyny Ddoswiadczalnej 67 481-490. (doi:10.5604/17322693.1050999)
75. Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P, Zhang Y, Shan Z, Teng W & Xing M 2009 Association of high iodine intake with the T1799 BRAF mutation in papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 94 1612-1617. (doi:10.1210/jc.2008-2390)
76. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D & Guenel P 2007 Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. American Journal of Epidemiology 166 1140-1149. (doi:10.1093/aje/kwm204)
77. Guilhen AC, Bufalo NE, Morari EC, Leite JL, Assumpcao LV, Tincani AJ & Ward LS 2009 Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility. Clinical Cancer Research 15 406-412. (doi:10.1158/1078-0432.CCR-08-1835)
78. Haber MH & Lipkovic P 1970 Thyroid cancer in Hawaii. Cancer 25 1224-1227. (doi:10.1002/1097-0142(197005)25:5〈1224::AIDCNCR2820250530〉3.0.CO;2-R)
79. Haggar FA, Preen DB, Pereira G, Holman CD & Einarsdottir K 2012. Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007. BMC Cancer 12 151. (doi:10.1186/1471-2407-12-151)
80. Hamatani K, Eguchi H, Ito R, Mukai M, Takahashi K, Taga M, Imai K, Cologne J, Soda M, Arihiro K et al. 2008 RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Research 68 7176-7182. (doi:10.1158/0008-5472.CAN-08-0293)
81. Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, Song DE, Hong SJ, Bae SJ, Kim HK, Shin MH et al. 2013 Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. European Journal of Endocrinology 168 879-886. (doi:10.1530/EJE-13-0065)
82. Hansell A & Oppenheimer C 2004 Health hazards from volcanic gases: a systematic literature review. Archives of Environmental Health 59 628-639. (doi:10.1080/00039890409602947)
83. Heer M & Egert S 2014 Nutrients other than carbohydrates: their effects on glucose homeostasis in humans. Diabetes/Metabolism Research and Reviews [in press]. (doi:10.1002/dmrr.2533)
84. Hernandez A, Cespedes W, Xamena N, Surralles J, Creus A, Galofre P & Marcos R 2003 Glutathione S-transferase polymorphisms in thyroid cancer patients. Cancer Letters 190 37-44. (doi:10.1016/S0304-3835(02)00580-3)
85. Hillebrandt S, Streffer C, Reiners C & Demidchik E 1996 Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident. International Journal of Radiation Biology 69 39-45. (doi:10.1080/095530096146165)
86. Hinther A, Edwards TM, Guillette LJ Jr & Helbing CC 2012 Influence of nitrate and nitrite on thyroid hormone responsive and stress-associated gene expression in cultured Rana catesbeiana tadpole tail fin tissue. Frontiers in Genetics 3 51. (doi:10.3389/fgene.2012.00051)
87. Ho T, Zhao C, Zheng R, Liu Z, Wei Q & Sturgis EM 2006 Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Archives of Otolaryngology - Head & Neck Surgery 132 756-761. (doi:10.1001/archotol.132.7.756)
88. Hogan DE & Bearden J 2007 Volcanic eruptions. In Disaster Medicine, ch 24, pp 266-276. Eds DE Hogan & JL Burstein. Philadelphia, PA: WW Lippincott.
89. Hoskins JM, Carey LA & McLeod HL 2009 CYP2D6 and tamoxifen: DNA matters in breast cancer. Nature Reviews. Cancer 9 576-586. (doi:10.1038/nrc2683)
90. How J & Tabah R 2007 Explaining the increasing incidence of differentiated thyroid cancer. Canadian Medical Association Journal 177 1383-1384. (doi:10.1503/cmaj.071464)
91. Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z et al. 2013 SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
92. Husson O, Haak HR, van Steenbergen LN, Nieuwlaat WA, van Dijk BA, Nieuwenhuijzen GA, Karim-Kos H, Kuijpens JL, van de Poll-Franse LV & Coebergh JW 2013 Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989. Endocrine-Related Cancer 20 263-271. (doi:10.1530/ERC-12-0336)
93. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 2006 Vanadium pentoxide. In Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide, pp 227-292. Eds IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC Press.
94. Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, Ashizawa K, Hida A, Soda M, Fujiwara S et al. 2006 Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. Journal of the American Medical Association 295 1011-1022. (doi:10.1001/jama.295.9.1011)
95. Jasani B & Butel JS 2013 Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen? Leukemia Research 37 607-608. (doi:10.1016/j.leukres.2013.03.008)
96. Jensen K, Patel A, Larin A, Hoperia V, Saji M, Bauer A, Yim K, Hemming V & Vasko V 2010 Human herpes simplex viruses in benign and malignant thyroid tumours. Journal of Pathology 221 193-200. (doi:10.1002/path.2701)
97. Jooste PL, Weight MJ, Kriek JA & Louw AJ 1999 Endemic goitre in the absence of iodine deficiency in schoolchildren of the Northern Cape Province of South Africa. European Journal of Clinical Nutrition 53 8-12. (doi:10.1038/sj.ejcn.1600671)
98. Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA Jr, Sigurdson AJ & Nikiforov YE 2014 The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. Journal of Clinical Endocrinology and Metabolism 99 E276-E285. (doi:10.1210/jc.2013-2503)
99. Kabat GC, Kim MY, Wactawski-Wende J & Rohan TE 2012 Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiology 36 335-340. (doi:10.1016/j.canep.2012.03.013)
100. Karim-Kos HE, Kiemeney LA, Louwman MW, Coebergh JW & de Vries E 2012 Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation. International Journal of Cancer 130 2981-2989. (doi:10.1002/ijc.26315)
101. Kawano M, Hasegawa J, Enomoto T, Onishi H, Nishio Y, Matsuda M & Wakimoto T 2005 Hydroxylated polychlorinated biphenyls (OH-PCBs): recent advances in wildlife contamination study. Environmental Sciences 12 315-324.
102. Kazakov VS, Demidchik EP & Astakhova LN 1992 Thyroid cancer after Chernobyl. Nature 359 21. (doi:10.1038/359021a0)
103. Kelly GL, Stylianou J, Rasaiyaah J, Wei W, Thomas W, Croom-Carter D, Kohler C, Spang R, Woodman C, Kellam P et al. 2013 Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature. Journal of Virology 87 2882-2894. (doi:10.1128/JVI.03003-12)
104. Khan MS, Pandith AA, Ul Hussain M, Iqbal M, Khan NP, Wani KA, Masoodi SR & Mudassar S 2013 Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study). Tumor Biology 34 521-529. (doi:10.1007/s13277-012-0577-y)
105. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL et al. 2009 International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes & Control 20 525-531. (doi:10.1007/s10552-008-9260-4)
106. Kilfoy BA, Zhang Y, Park Y, Holford TR, Schatzkin A, Hollenbeck A & Ward MH 2011 Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study. International Journal of Cancer 129 160-172. (doi:10.1002/ijc.25650)
107. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE & Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research 63 1454-1457.
108. Kiseljak-Vassiliades K & Xing M 2011 Association of cigarette smoking with aberrant methylation of the tumor suppressor gene RARb 2 in papillary thyroid cancer. Frontiers in Endocrinology 2 99. (doi:10.3389/fendo.2011.00099)
109. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, Schairer C, Schatzkin A, Shikany JM & Berrington de Gonzalez A 2011 Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiology, Biomarkers & Prevention 20 464-472. (doi:10.1158/1055-9965.EPI-10-1220)
110. Klugbauer S, Lengfelder E, Demidchik EP & Rabes HM 1995 High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11 2459-2467.
111. Knobel M & Medeiros-Neto G 2007 Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia 51 701-712. (doi:10.1590/S0004-27302007000500007)
112. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH & Hinds MW 1990 An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes & Control 1 223-234. (doi:10.1007/BF00117474)
113. Kreiger N & Parkes R 2000 Cigarette smoking and the risk of thyroid cancer. European Journal of Cancer 36 1969-1973. (doi:10.1016/S0959-8049(00)00198-2)
114. Kristbjornsdottir A & Rafnsson V 2013 Cancer incidence among population utilizing geothermal hot water: a census-based cohort study. International Journal of Cancer 133 2944-2952. (doi:10.1002/ijc.28298)
115. Kroemer HK & Eichelbaum M 1995 "It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Life Sciences 56 2285-2298. (doi:10.1016/0024-3205(95)00223-S)
116. Kung TM, Ng WL & Gibson JB 1981 Volcanoes and carcinoma of the thyroid: a possible association. Archives of Environmental Health 36 265-267. (doi:10.1080/00039896.1981.10667635)
117. Kusky TM 2003 Volcanic eruptions. In Geological Hazards: A Source Book, ch 3, pp 49-74. Ed TM Kusky. Westport, CT: Greenwood Publishing Group.
118. Lawrence JE, Lamm SH, Pino S, Richman K & Braverman LE 2000 The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid 10 659-663. (doi:10.1089/10507250050137734)
119. Lee TJ, Kim S, Cho HJ & Lee JH 2012 The incidence of thyroid cancer is affected by the characteristics of a healthcare system. Journal of Korean Medical Science 27 1491-1498. (doi:10.3346/jkms.2012.27.12.1491)
120. Leite JL, Bufalo NE, Santos RB, Romaldini JH & Ward LS 2010 Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease. European Journal of Endocrinology 162 315-321. (doi:10.1530/EJE-09-0719)
121. Li JL, Long J, Hu Y, Tan A, Guo X & Zhang S 2012 Glutathione S-transferase M1, T1, and P1 polymorphisms and thyroid cancer risk: a metaanalysis. Cancer Epidemiology 36 e333-e340. (doi:10.1016/j.canep.2012.06.002)
122. Li N, Du XL, Reitzel LR, Xu L & Sturgis EM 2013 Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the Surveillance, Epidemiology, and End Results registry, 1980-2008. Thyroid 23 103-110. (doi:10.1089/thy.2012.0392)
123. Lima J, Trovisco V, Soares P, Maximo V, Magalhaes J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A et al. 2004 BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 89 4267-4271. (doi:10.1210/jc.2003-032224)
124. Lope V, Perez-Gomez B, Aragones N, Lopez-Abente G, Gustavsson P, Plato N, Silva-Mato A & Pollan M 2009 Occupational exposure to chemicals and risk of thyroid cancer in Sweden. International Archives of Occupational and Environmental Health 82 267-274. (doi:10.1007/s00420-008-0314-4)
125. Ludlow JW 1993 Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB Journal 7 866-871.
126. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C et al. 2003 A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes & Control 14 773-785. (doi:10.1023/A:1026349702909)
127. Malandrino P, Scollo C, Marturano I, Russo M, Tavarelli M, Attard M, Richiusa P, Violi MA, Dardanoni G, Vigneri R et al. 2013 Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor". Frontiers in Endocrinology 4 65. (doi:10.3389/fendo.2013.00065)
128. Marcello MA, Sampaio AC, Geloneze B, Vasques AC, Assumpcao LV & Ward LS 2012 Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutrition and Cancer 64 1190-1195. (doi:10.1080/01635581.2012.721154)
129. Marcello MA, Morari EC, Cunha LL, De Nadai Silva AC, Carraro DM, Carvalho AL, Soares FA, Vassallo J & Ward LS 2013 P53 and expression of immunological markers may identify early stage thyroid tumors. Clinical & Developmental Immunology 2013 846584. (doi:10.1155/2013/846584)
130. Marciniak P, Drobnik K, Ziemnicka K, Gut P, Slomski R & Sowinski J 2006 Transferase S-glutathione class p gene (GSTP1) polymorphism in thyroid cancer patients. Endokrynologia Polska 57 509-515.
131. Marsh G, Bergman A, Bladh L-G, GillnerM& Jakobsson E 1998 Synthesis of p-hydroxybromodiphenyl ethers and binding to the thyroid receptor. Organohalogen Compounds 37 305-308.
132. Martin-Del Pozzo AL, Aceves F, Espinasa R, Aguayo A, Inguag-Giato S, Morales P & Cienfuegos E 2002 Influence of volcanic activity on spring water chemistry at Popocatepetl Volcano, Mexico. Chemical Geology 190 207-229. (doi:10.1016/S0009-2541(02)00117-1)
133. Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O & Kebebew E 2011 Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 117 4390-4395. (doi:10.1002/cncr.26072)
134. Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM & Martin PM 2011 Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. British Journal of Cancer 104 332-337. (doi:10.1038/sj.bjc.6606048)
135. McNally RJ, Blakey K, James PW, Gomez Pozo B, Basta NO & Hale J 2012 Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. European Journal of Epidemiology 27 615-622. (doi:10.1007/s10654-012-9710-x)
136. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS & Berrington de Gonzalez A 2010 Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. American Journal of Epidemiology 171 242-252. (doi:10.1093/aje/kwp354)
137. Mirvish SS 1995 Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Letters 93 17-48. (doi:10.1016/0304-3835(95)03786-V)
138. Morari EC, Leite JL, Granja F, da Assumpcao LV & Ward LS 2002 The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiology, Biomarkers & Prevention 11 1485-1488.
139. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H & Nakao K 2002 Thyroid hormone action is disrupted by bisphenol A as an antagonist. Journal of Clinical Endocrinology and Metabolism 87 5185-5190. (doi:10.1210/jc.2002-02020)
140. Morris LG, Sikora AG, Tosteson TD & Davies L 2013 The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23 885-891. (doi:10.1089/thy.2013.0045)
141. Nagano J, Mabuchi K, Yoshimoto Y, Hayashi Y, Tsuda N, Land C & Kodama K 2007 A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer. Journal of Epidemiology 17 76-85. (doi:10.2188/jea.17.76)
142. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M & Shimaoka K 1994 Thyroid diseases among atomic bomb survivors in Nagasaki. Journal of the American Medical Association 272 364-370. (doi:10.1001/jama.1994.03520050044028)
143. Nauman J & Wolff J 1993 Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. American Journal of Medicine 94 524-532. (doi:10.1016/0002-9343(93)90089-8)
144. Nikiforov YE & Nikiforova MN 2011 Molecular genetics and diagnosis of thyroid cancer. Nature Reviews. Endocrinology 7 569-580. (doi:10.1038/nrendo.2011.142)
145. Nikiforov YE, Nikiforova MN, Gnepp DR & Fagin JA 1996 Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene 13 687-693.
146. Noch E & Khalili K 2012 Oncogenic viruses and tumor glucose metabolism: like kids in a candy store. Molecular Cancer Therapeutics 11 14-23. (doi:10.1158/1535-7163.MCT-11-0517)
147. Ozdarendeli A, Camci C, Aygen E, Kirkil C, Toroman ZA, Dogru O & Doymaz MZ 2004 SV40 in human thyroid nodules. Journal of Clinical Virology 30 337-340. (doi:10.1016/j.jcv.2003.12.008)
148. Parker LN, Belsky JL, Yamamoto T, Kawamoto S & Keehn RJ 1974 Thyroid carcinoma after exposure to atomic radiation. A continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971. Annals of Internal Medicine 80 600-604. (doi:10.7326/0003-4819-80-5-600)
149. Pathak KA, Leslie WD, Klonisch TC & Nason RW 2013 The changing face of thyroid cancer in a population-based cohort. Cancer Medicine 2 537-544. (doi:10.1002/cam4.103)
150. Pearce EN & Braverman LE 2009 Environmental pollutants and the thyroid. Best Practice & Research. Clinical Endocrinology & Metabolism 23 801-813. (doi:10.1002/cam4.103)
151. Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F et al. 2009 Papillary thyroid cancer incidence in the volcanic area of Sicily. Journal of the National Cancer Institute 101 1575-1583. (doi:10.1093/jnci/djp354)
152. Pipas JM 1992 Common and unique features of T antigens encoded by the polyomavirus group. Journal of Virology 66 3979-3985.
153. Raab-Traub N 2002 Epstein-Barr virus in the pathogenesis of NPC. Seminars in Cancer Biology 12 431-441. (doi:10.1016/S1044579X0200086X)
154. Rayman MP 2000 The importance of selenium to human health. Lancet 356 233-241. (doi:10.1016/S0140-6736(00)02490-9)
155. Rego-Iraeta A, Perez-Mendez LF, Mantinan B & Garcia-Mayor RV 2009 Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 19 333-340. (doi:10.1089/thy.2008.0210)
156. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F & Niepomniszcze H 2008 Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 18 461-464. (doi:10.1089/thy.2007.0223)
157. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F & Niepomniszcze H 2009a High prevalence of thyroid nodules in patients with achrocordons (skin tags). Possible role of insulin-resistance. Medicina 69 302-304.
158. Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F & Niepomniszcze H 2009b Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metabolic Syndrome and Related Disorders 7 375-380. (doi:10.1089/met.2008.0062)
159. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA & Reynolds J 1991 Thyroid cancer: a lethal endocrine neoplasm. Annals of Internal Medicine 115 133-147. (doi:10.7326/0003-4819-115-2-133)
160. Roccaro P, Barone C, Mancini G & Vagliasindi FGA 2007 Removal of manganese from water supplies intended for human consumption: a case study. Desalination 210 205-214. (doi:10.1016/j.desal.2006.05.045)
161. Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA, Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova MV, Petoukhova NS et al. 2006 TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncology Reports 15 949-956. (doi:10.3892/or.15.4.949)
162. Romei C, Fugazzola L, Puxeddu E, Frasca F, Viola D, Muzza M, Moretti S, Nicolosi ML, Giani C, Cirello V et al. 2012 Modifications in the papillary thyroid cancer gene profile over the last 15 years. Journal of Clinical Endocrinology and Metabolism 97 E1758-E1765. (doi:10.1210/jc.2012-1269)
163. Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT & Fraumeni JF Jr 1987 A population-based case-control study of thyroid cancer. Journal of the National Cancer Institute 79 1-12. (doi:10.1093/jnci/79.1.1)
164. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA & Boice JD Jr 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 141 259-277. (doi:10.2307/3579003)
165. Rossing MA, Cushing KL, Voigt LF, Wicklund KG & Daling JR 2000 Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 11 49-54. (doi:10.1097/00001648-200001000-00011)
166. Santini F, Mantovani A, Cristaudo A, Rago T, Marsili A, Buselli R, Mignani A, Ceccarini G, Bastillo R, Taddei D et al. 2008 Thyroid function and exposure to styrene. Thyroid 18 1065-1069. (doi:10.1089/thy.2008.0003)
167. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G & Fusco A 1994 Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene 9 509-516.
168. Santoro M, Melillo RM & Fusco A 2006 RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. European Journal of Endocrinology 155 645-653. (doi:10.1530/eje.1.02289)
169. Simard EP, Ward EM, Siegel R & Jemal A 2012 Cancers with increasing incidence trends in the United States: 1999 through 2008. CA: A Cancer Journal for Clinicians 62 118-128. (doi:10.3322/caac.20141)
170. Siraj AK, Ibrahim M, Al-Rasheed M, Abubaker J, Bu R, Siddiqui SU, Al-Dayel F, Al-Sanea O, Al-Nuaim A, Uddin S et al. 2008 Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. BMC Medical Genetics 9 61. (doi:10.1186/1471-2350-9-61)
171. Smith C 2013 EBV and nasopharyngeal carcinoma: a target for cellular therapies. Immunotherapy 5 821-824. (doi:10.2217/imt.13.68)
172. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R & Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22 4578-4580. (doi:10.1038/sj.onc.1206706)
173. Sokic SI, Adanja BJ, Vlajinac HD, Jankovic RR, Marinkovic JP & Zivaljevic VR 1994 Risk factors for thyroid cancer. Neoplasma 41 371-374.
174. Stewart BW & Kleihues P 2003. The causes of cancer. In World Cancer Report, ch 2, pp. 21-81. Eds BW Stewart & P Kleihues. Lyon: IARC Press.
175. Suchy B, Waldmann V, Klugbauer S & Rabes HM 1998 Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. British Journal of Cancer 77 952-955. (doi:10.1038/bjc.1998.157)
176. Suzuki T, Matsuo K,Wakai K, Hiraki A, Hirose K, Sato S, Ueda R & Tajima K 2007 Effect of familial history and smoking on common cancer risks in Japan. Cancer 109 2116-2123. (doi:10.1002/cncr.22685)
177. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G et al. 1999 High prevalence of RET /PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET /PTC3 and the solid-follicular variant. Journal of Clinical Endocrinology and Metabolism 84 4232-4238. (doi:10.1210/jcem.84.11.6129)
178. Tilling R & Jones BF 1996 Waters associated with an active basaltic volcano, Kilauea, Kawaii: variation in solute sources, 1973-1991. Geological Society of America Bulletin 108 562-577. (doi:10.1130/0016-7606(1996)108〈0562:WAWAAB〉2.3.CO;2)
179. Tonacchera M, Pinchera A, Dimida A, Ferrarini E, Agretti P, Vitti P, Santini F, Crump K & Gibbs J 2004 Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid 14 1012-1019. (doi:10.1089/thy.2004.14.1012)
180. Truong T, Rougier Y, Dubourdieu D, Guihenneuc-Jouyaux C, Orsi L, Hemon D & Guenel P 2007 Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999). European Journal of Cancer Prevention 16 62-70. (doi:10.1097/01.cej.0000236244.32995.e1)
181. Truong T, Baron-Dubourdieu D, Rougier Y & Guenel P 2010 Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes & Control 21 1183-1192. (doi:10.1007/s10552-010-9545-2)
182. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL & Yang CC 2005 Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. Journal of Medical Virology 75 276-281. (doi:10.1002/jmv.20267)
183. Tuttle RM & Becker DV 2000 The Chernobyl accident and its consequences: update at the millennium. Seminars in Nuclear Medicine 30 133-140. (doi:10.1053/nm.2000.5412)
184. Uthus EO & Nielsen FH 1990 Effect of vanadium, iodine and their interaction on growth, blood variables, liver trace elements and thyroid status indices in rats. Magnesium and Trace Elements 9 219-226.
185. Vineis P 2002 The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181-182 457-462. (doi:10.1016/S0300-483X(02)00450-X)
186. Vivaldi A, Pacini F, Martini F, Iaccheri L, Pezzetti F, Elisei R, Pinchera A, Faviana P, Basolo F & Tognon M 2003 Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes. Journal of Clinical Endocrinology and Metabolism 88 892-899. (doi:10.1210/jc.2002-020436)
187. Wang H, Yang Z, Zhou B, Gao H, Yan X & Wang J 2009 Fluoride-induced thyroid dysfunction in rats: roles of dietary protein and calcium level. Toxicology and Industrial Health 25 49-57. (doi:10.1177/0748233709102720)
188. Ward MH, Kilfoy BA, Weyer PJ, Anderson KE, Folsom AR & Cerhan JR 2010 Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 21 389-395. (doi:10.1097/EDE.0b013e3181d6201d)
189. Wartofsky L 2010 Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones 9 103-108. (doi:10.14310/horm.2002.1260)
190. Welch HG & Black WC 2010 Overdiagnosis in cancer. Journal of the National Cancer Institute 102 605-613. (doi:10.1093/jnci/djq099)
191. Wiersinga WM 2013 Smoking and thyroid. Clinical Endocrinology 79 145-151. (doi:10.1111/cen.12222)
192. Williams D 2002 Cancer after nuclear fallout: lessons from the Chernobyl accident. Nature Reviews. Cancer 2 543-549. (doi:10.1038/nrc845)
193. Winship T & Rosvoll RV 1970 Cancer of the thyroid in children. Proceedings. National Cancer Conference 6 677-681.
194. Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Feng Z, Thomas DB & Checkoway H 2006 Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. International Archives of Occupational and Environmental Health 79 251-258. (doi:10.1007/s00420-005-0036-9)
195. Yang T, Namba H, Hara T, Takmura N, Nagayama Y, Fukata S, Ishikawa N, Kuma K, Ito K & Yamashita S 1997 p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells. Oncogene 14 1511-1519. (doi:10.1038/sj.onc.1200979)
196. Yarilin AA, Belyakov IM, Kusmenok OI, Arshinov VY, Simonova AV, Nadezhina NM & Gnezditskaya EV 1993 Late T cell deficiency in victims of the Chernobyl radiation accident: possible mechanisms of induction. International Journal of Radiation Biology 63 519-528 (doi:10.1080/09553009314550681)
197. 131I from radioactive fallout. Health Physics 78 660-667. (doi:10.1097/00004032-200006000-00008)
198. Zhang Y, Guo GL, Han X, Zhu C, Kilfoy BA, Zhu Y, Boyle P & Zheng T 2008 Do polybrominated diphenyl ethers (PBDEs) increase the risk of thyroid cancer? Bioscience Hypotheses 1 195-199. (doi:10.1016/j.bihy.2008.06.003)
199. Zhang Q, Song F, Zheng H, Zhu X, Yao X, Zhang L & Chen K 2013 Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population. Thyroid 23 38-44. (doi:10.1089/thy.2012.0228)
200. Zhou T, Ross DG, DeVito MJ & Crofton KM 2001 Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicological Sciences 61 76-82. (doi:10.1093/toxsci/61.1.76)
201. Ziegler JL 1993 Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 342 1348-1351. (doi:10.1016/0140-6736(93)92252-O)
202. Zoeller RT, Bansal R & Parris C 2005 Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 146 607-612.(doi:10.1210/en.2004-1018)